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Over 450 transfer RNA (tRNA) genes have been annotated in the human genome. Reliable quantitation of tRNA levels
in human samples using microarray methods presents a technical challenge. We have developed a microarray method
to quantify tRNAs based on a fluorescent dye-labeling technique. The first-generation tRNA microarray consists of 42
probes for nuclear encoded tRNAs and 21 probes for mitochondrial encoded tRNAs. These probes cover tRNAs for all
20 amino acids and 11 isoacceptor families. Using this array, we report that the amounts of tRNA within the total
cellular RNA vary widely among eight different human tissues. The brain expresses higher overall levels of nuclear
encoded tRNAs than every tissue examined but one and higher levels of mitochondrial encoded tRNAs than every
tissue examined. We found tissue-specific differences in the expression of individual tRNA species, and tRNAs decoding
amino acids with similar chemical properties exhibited coordinated expression in distinct tissue types. Relative tRNA
abundance exhibits a statistically significant correlation to the codon usage of a collection of highly expressed, tissue-
specific genes in a subset of tissues or tRNA isoacceptors. Our findings demonstrate the existence of tissue-specific
expression of tRNA species that strongly implicates a role for tRNA heterogeneity in regulating translation and possibly
additional processes in vertebrate organisms.
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Introduction
Human tissues contain common and distinct macromolec-
ular components in varying amounts. Large-scale, high-
throughput analyses of mRNA expression in human tissues
show tissue-speciﬁc gene expression (e.g., [1–3]). Transfer
RNA (tRNA) plays a central role in translating the mRNA
sequence into the protein sequence. Approximately 450 tRNA
genes have been annotated in the human genome [4,5] (http://
lowelab.ucsc.edu/GtRNAdb/Hsapi). These tRNA genes are
scattered throughout the genome and are present on all but
the Y chromosome. Twenty-two additional tRNA genes are
present in human mitochondrial DNA [6,7]. Thus, there are
approximately 473 human tRNAs that are grouped into 49
isoacceptor families to decode the 21 amino acids speciﬁed by
the genetic code (20 standard amino acids and selenocysteine).
To our knowledge, no systematic studies of tRNA expres-
sion among human tissues have been published. The dearth of
information on tRNA expression is the result of technical and
intellectual obstacles. Accurate quantitation of individual
tRNA species is challenging due to the extensive secondary
and tertiary structure of tRNA and numerous post-transcrip-
tional modiﬁcations [8], both of which interfere with reverse
transcription and hybridization of short oligonucleotides.
Enthusiasm for tackling this challenge was low because prior
to the human genome sequencing project, human tRNAs were
considered to be no more diverse than those in unicellular
organisms [8,9]. Complete sequencing of the human genome
revealed, however, that over 270 different tRNA sequences are
present among approximately 450 tRNA genes. Since only 61
possible anticodons are speciﬁed by the triplet code, there are
many distinct tRNA species with identical anticodons, but
they contain sequence differences in the tRNA body. This
sequence diversity is not an inevitable result of genetic drift in
multicopy genes over the course of evolution but may also be
of some functional relevance [10]. In stark contrast to
vertebrate genomes, there are only 51 different tRNA
sequences among 274 yeast tRNA genes [4,5,11].
Why should the human genome contain such a diverse
array of tRNA sequences? A compelling explanation is that
controlling expression of individual tRNA species enables
another level of translational control for speciﬁc gene
products. In bacteria and yeast, differences in the relative
abundance of tRNA isoacceptors for a given amino acid
clearly impact the synthesis of highly expressed proteins
[12,13]. Codon bias in tissue-speciﬁcally expressed genes have
been reported, prompting the insight that such biases may be
related to potential tissue-dependent differences in tRNA
expression [14]. tRNA is also the dominant ligand for the
elongation factor 1a (EF-1a). Given the myriad supratransla-
tional functions of EF-1a [15,16] in cellular physiology,
variations in tRNA expression could inﬂuence these pro-
cesses which include bundling of actins and disassembly of
microtubules [17,18]. For these reasons, even a rudimentary
analysis of tRNA expression in human tissues could reveal
novel aspects of human tRNA biology.
Here we describe the comparative analysis of tRNA levels
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microarray method adapted from our previously developed
arrays for bacterial tRNAs [19,20]. Our human tRNA micro-
array contains 42 probes for nuclear encoded tRNAs and 21
probes for mitochondrial encoded tRNAs. These probes
cover tRNAs for all amino acids with enough sequence
differences to be uniquely distinguished. Our results show
that tRNA levels vary widely among human tissues and
coordinate according to the properties of their cognate
amino acids. The differences in relative expression of tRNA
isoacceptors in several tissues show statistically signiﬁcant
correlation to codon usage of a group of approximately 15 to
40 of tissue-speciﬁc genes that are expressed at the highest
levels among tissue-speciﬁc genes.
Results/Discussion
Design and Specificity of Microarrays for Human tRNA
tRNA was quantiﬁed by taking advantage of its universally
conserved 39CCA sequence to attach a ﬂuorescently labeled
probe to tRNA present in total RNA prepared from tissues or
cell lines. tRNA labeled in this manner was hybridized to DNA
probes arrayed on glass slides. The brain sample was included
in all hybridizations to correct for the variations in
ﬂuorescence labeling and array manufacturing. We used
probes that are 70 to 80 nucleotides long, covering the length
of the entire tRNA minus the conserved 39CCA sequence.
Probes at these lengths signiﬁcantly increase hybridization
efﬁciency and eliminate the sensitivity to potential variations
in post-transcriptional modiﬁcations [19]. We designed the
probes for nuclear tRNA genes to distinguish expression
between tRNA isoacceptors, i.e., tRNAs with different
anticodon sequences that read the codons for the same
amino acid. Often, an isoacceptor family is encoded by
multiple highly homologous genes. For example, ﬁve tRNA
Arg
isoacceptors read the six arginine codons.
Our work on bacterial tRNAs showed that two tRNAs
having more than ten different residues can be generally
distinguished on a microarray, whereas signiﬁcant cross-
hybridization occurs when the sequence difference between
two tRNAs is less than eight [19]. Sequence alignment by
Clustal X [21] shows that there are sufﬁcient sequence
differences between tRNA
Arg isoacceptors (more than ten
among 70 to 75 residues) to enable design of three
isoacceptor probes that separately cover tRNA genes with
ACG (modiﬁed to ICG [22]), CCT, or TCT anticodons. Since
sequence differences between tRNA
Arg with CCG and TCG
anticodons are insufﬁcient (fewer than eight in 70 to 75
residues) to allow the design of two distinct probes, a single
probe is used for these tRNAs. Thirty-seven probes are
designed in this way to cover the 49 human tRNA
isoacceptors plus the initiator tRNA
Met (Tables S1 and S2).





Thr(CGT) isoacceptors are distinct
enough that separate probes can be designed for their
individual tRNA genes. The mitochondrial encoded tRNA
sequences are sufﬁciently different so that 21 probes are
designed to cover all mitochondrial tRNA genes except
tRNA
Glu (Tables S3 and S4).
We established the speciﬁcity of the human tRNA array by
examining the cross-hybridization of probes designed to
detect tRNAs from different organisms (Figure 1). Based on
sequence conservation, most of the 42 probes for human
nuclear encoded tRNAs should hybridize to mouse tRNAs as
well as to some Drosophila and Caenorhabditis elegans tRNAs
[4,5]. Mitochondrial tRNA genes between human and mouse
are sufﬁciently unique that 18 distinct probes for mouse
mitochondrial tRNAs are present on the array. Approx-
imately two-thirds of the Drosophila tRNAs and one-third of
the C. elegans tRNAs have sufﬁcient sequence similarity to
human tRNAs that the same probes are used for these tRNAs.
Ten separate probes for Drosophila and 34 probes for C. elegans
tRNAs are also included on the array.
The microarray was tested using total RNA isolated from
HeLa cells, mouse kidney, and entire C. elegans. Figure 1B
shows one of the representative 32 blocks on the microarray.
This block contains two to four repeats each of nine human
probes, two mouse mitochondrial probes, six Drosophila or C.
elegans probes, three probes as negative controls, and four
blank spots. When HeLa total RNA was used, eight of nine
human probes showed signals ranging from weak to strong.
No signals were detected from the two mouse mitochondrial
tRNA probes. Weak signals could be seen on one of the three
negative control probes and two of six Drosophila and C. elegans
probes. When mouse kidney total RNA was applied to the
array, the two mouse mitochondrial tRNA probes showed
intermediate to strong signals. When C. elegans total RNA was
applied, all ten homologous probes showed weak to strong
signals, with only a lone Drosophila probe showing a weak
signal among the non–C. elegans probes. Using HeLa RNA,
probes for human tRNAs show signiﬁcantly higher hybrid-
ization signals than nonhuman probes (Figure 1C). Hybrid-
ization to all but one nonhuman probe yields signals that are
lower than 10% of the strongest signals among the human
tRNA probes. A single exception is the strong hybridization
to the C. elegans tRNA
His probe which is not predicted by
sequence similarity. These results show that the speciﬁcity of
the microarray is sufﬁciently high given the extensive
conservation among tRNAs between these organisms and
supports its validity for measuring speciﬁc differences in
tRNA expression.
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Synopsis
Transfer RNAs (tRNAs) translate the genetic code of genes into the
amino acid sequence of proteins. Most amino acids have two or
more codons. Every organism has multiple tRNA species reading the
codons for the same amino acid (tRNA isoacceptors). In bacteria and
yeast, differences in the relative abundance of tRNA isoacceptors
have been found to affect the level of highly expressed proteins.
This tRNA abundance–codon distribution relationship can have
predictive power on the expression of genes based on their codon
usages. Approximately 450 tRNA genes consisting of 49 isoacceptors
and 274 different sequences have been annotated in the human
genome. This work describes the first comparative analysis of tRNA
expression levels in eight human tissues using microarray methods.
The authors find significant, tissue-specific differences in the
expression of tRNA species and coordinated expression among
tRNAs decoding amino acids with similar chemical properties in
distinct tissue types. Correlation of relative tRNA abundance versus
the codon usage of highly expressed, tissue-specific genes can be
found among a subset of tissues or tRNA isoacceptors. Differential
tRNA expression in human tissues suggests that tRNA may play a
unique role in regulating translation and possibly other processes in
humans.To determine the appropriate dynamic range for the
ﬂuorescent dye ratios, serial dilutions of total RNA from
HeLa were performed (Figure 1D). The dynamic range is at
least two orders of magnitude as the dye ratios remain within
a constant threshold of 1.25-fold. This result also suggests a
detection limit of 1.25-fold for measured changes in tRNA
abundance between two human samples. In bacteria and
yeast, the relative abundance between tRNA members in an
isoacceptor family ranges from 1-fold to 20-fold [23–26]. Our
microarray is clearly capable of detecting differences within
this range.
tRNA Expression in Human Tissues and Cell Lines
In unicellular prokaryotes and eukaryotes, the abundance
of tRNA isoacceptors is correlated with codon preferences
among genes encoding highly expressed proteins, e.g.,
ribosomal proteins [11,27,28]. Mining mRNA microarray
expression data, Plotkin et al. [14] reported the existence of
tissue-based codon bias in paralogous genes; they proposed
that this codon bias is related to tissue-speciﬁc differences in
the abundance of corresponding decoding tRNAs. To explore
this intriguing hypothesis, we used our microarray to measure
the relative tRNA expression between eight tissues: brain,
liver, vulva, testis and ovary, thymus, lymph node, and spleen.
We included the latter three immune tissues based on an
unexpected consequence of human genome sequencing: the
single largest cluster of tRNA genes resides in the gene cluster
of the major histocompatibility complex (also known as the
human leukocyte antigen complex) [29]. The existence of
one-third of all human tRNA genes in the human leukocyte
antigen complex suggests that expression of these genes may
be related to immune system function. For example, a high
expression level of tRNA in this region may facilitate high
expression of histocompatibility complex genes following a
signaling event [29].
Microarray results show overall variations in the expression
levels of tRNA among different tissues (Figures 2 and S1). For
example, all tRNAs in ovary have lower levels relative to
brain. Some tRNAs in spleen have higher, while others have
lower levels, compared to those in brain (Figure 2A). Within
individual tissues, the maximal differences between the
relative tRNA levels can be as large as approximately tenfold
(e.g., vulva, thymus) or only approximately threefold (e.g.,
testis).
Nuclear and mitochondrial encoded tRNA levels can be
approximated separately by the mean and median tissue-to-
brain ratio (Figure 2B and 2C). Liver and vulva have
approximately two-thirds the amount of tRNA present in
brain, while the reproductive tissues of testis and ovary
express approximately one-third as much tRNA as the brain.
Among the three immune tissues, thymus is comparable to
liver and vulva, lymph node is similar to the reproductive
Figure 1. The tRNA Microarray
(A) Schematics of fluorescence labeling of tRNA in a total RNA mixture. Ribonucleotides in the labeling oligos are shown in blue, and
deoxyribonucleotides are shown in black. 5-NU, 5-allylamino-uridine; p, 59 phosphate. All tissue samples are labeled with Cy3 and Cy5. At least two
arrays are run for every sample pair. Array 1 used Cy3-labeled sample No. 1 and Cy5-labeled sample No. 2, and array 2 used Cy5-labeled sample No. 1
and Cy3-labeled sample No. 2.
(B) Microarray images of one of the 32 blocks containing 100 spots hybridized with samples from HeLa (H), mouse kidney (M), and C. elegans whole
animal (C). In the schematics below, black squares indicate the position of probes for the human (left), mouse (middle), and C. elegans (right) tRNAs.
(C) Fluorescence intensity of a HeLa sample hybridized to the nuclear encoded tRNA probes (left) or mitochondrial encoded tRNA probes (right).
‘‘Human’’ indicates signals for the designated human probes; ‘‘other,’’ signals for Drosophila and C. elegans probes; and ‘‘mouse,’’ signals for mouse
mitochondrial tRNA probes.
(D) Dynamic range of Cy5/Cy3 ratio changes as a function of Cy3 intensity.
doi:10.1371/journal.pgen.0020221.g001
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tRNA Expression in Human Tissuestissues, while spleen has similar tRNA levels as the brain. On
the other hand, the relative mitochondrial encoded tRNA
levels in all seven tissues are lower than that in brain, a result
that may reﬂect high mitochondrial translation activity in the
brain (e.g., [30]).
Since mature tRNA in human is thought to be very stable,
total tRNA levels likely reﬂect tRNA transcription rates [28].
tRNA is transcribed by multisubunit complexes of RNA
polymerase III, TFIIIB and TFIIIC [31,32]. Varying the
abundance of one or more of these protein factors as
suggested by results from mRNA expression arrays [1,2]
could lead to varying levels of transcription among tRNA
genes. On the other hand, the levels or activities of these
subunit components can also be controlled post-trascription-
ally and post-translationally. Understanding the basis for
tissue speciﬁc differences in total tRNA awaits direct
experimental examination of all of the potential factors.
Large differences in the relative abundance of individual
tRNAs from brain versus other tissues (e.g., ovary and spleen,
Figure 2A) are observed. For example, both tRNA
Ile iso-
acceptors in ovary are expressed at only one-tenth of the level
in brain, but these tRNAs in spleen are expressed above their
levels in brain. To facilitate evaluation of tissue-speciﬁc
differences in relative levels of individual tRNAs (Figure 3),
we normalized ﬂuorescent ratios internally to the separate
median values among the nuclear- (Figure 2B) and the
mitochondrial- (Figure 2C) encoded tRNAs.
Variations in the relative expression of tRNA isoacceptors
among tissues are readily observed, suggesting a possible
relationship between tRNA abundance and codon usage
among different tissues (Figure 3 and Table 1). For example,
among the members of the tRNA
Arg isoacceptor family, four
probes separate the ﬁve isoacceptor groups according to their
codon-reading capabilities: Arg-ICG reads CGU/C; Arg-YCG
Figure 2. Overview of Relative tRNA Abundance among Eight Human Tissues
Red line indicates the same level as brain.
(A) Relative ratios of each human tRNA probe for ovary or spleen versus brain sorted according to the ratios for ovary. Left, nuclear encoded tRNAs;
right, mitochondrial encoded tRNAs.
(B) Mean and median values of the nuclear tRNA probes for seven tissues versus brain.
(C) Mean and median values of the mitochondrial tRNA probes.
doi:10.1371/journal.pgen.0020221.g002
PLoS Genetics | www.plosgenetics.org December 2006 | Volume 2 | Issue 12 | e221 2110
tRNA Expression in Human TissuesFigure 3. Comparative Expression of Nuclear and Mitochondrial Encoded tRNAs among Eight Human Tissues and Two Cell Lines Shown as TreeView
Images [37]
All tissue data are normalized to the median ratio in Figure 2B and 2C. The mean and median values for the HeLa/HEK293 cell lines are 1.19 6 0.22 and
1.20 for nuclear tRNA probes and 1.48 6 0.37 and 1.42 for mitochondrial tRNA probes. Green indicates decreased level of expression; red, increased
level of expression in the indicated tissue over brain; gray, not determined due to very low signal intensity. Data are grouped according to codon-
reading abilities (isoacceptors) (A) and corresponding amino acid types (B).
doi:10.1371/journal.pgen.0020221.g003
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tRNA Expression in Human Tissuesreads CGA/G; Arg-CCT reads only AGG; and Arg-TCT reads
primarily AGA codons. A clear difference among these
tRNA
Arg isoacceptors can be seen among the brain and the
liver, thymus, and lymph node. Arg-TCT and Arg-CCT are
preferred over Arg-ICG and Arg-YCG in these nonbrain
tissues, suggesting a possible preference in reading AGA and
AGG codons. Another example is the tRNA
Lys isoacceptor
family. The AAG-reading isoacceptor is present in higher
amounts than the AAA-reading isoacceptor in almost all
tissues. This difference is particularly pronounced in vulva,
thymus, and lymph node. The same type of analysis can be
applied to tRNA isoacceptors for the glycine, isoleucine,
leucine, serine, threonine, and valine families (Table 1).
The relative expression of nuclear encoded tRNAs in two
commonly used cell lines (HeLa and HEK293) differs by less
than twofold and is quite similar among the isoacceptors
(Figures 3 and S1 and Table 1). This result suggests that tRNA
isoacceptor levels do not play a major role in differential
protein expression in these cell lines, even though they are
derived from different tissues (cervix and embryonic kidney).
This may also be a result of nontissue processes such as the
immortalized nature of these lines.
Interesting trends can be observed on the basis of the
cognate amino acid properties of tRNA (Figure 3B). tRNAs
and their corresponding amino acids can be divided into four
groups: hydrophobic (Ile, Leu, Met, Phe, Trp, and Val), small
(Ala, Cys, Gly, and Pro), charged (Arg, Asp, Glu, His, and Lys),
and polar (Asn, Gln, Ser, Se-Cys, Thr, and Tyr). Among the
nuclear encoded tRNAs, the three immune tissues (thymus,
lymph node, and spleen) contain increased levels of tRNA for
the hydrophobic group and decreased levels of tRNA for the
charged group compared to brain. In contrast, the two
reproductive tissues (testis and ovary) contain decreased
levels of tRNA for the hydrophobic group and increased
levels of tRNA for the small group. Trends for the liver and
vulva are more similar to those of the immune tissues, with
the increase in the tRNA for the hydrophobic group less
pronounced. In general, brain contains increased levels of
tRNA for the charged group (except for some tRNA
Arg
isoacceptors) and for the polar group (except for some
tRNA
Thr isoacceptors). The mitochondrial encoded tRNAs
show distinctly different trends compared to the nuclear
encoded tRNAs. The three immune tissues have decreased
levels of mitochondrial tRNA for the hydrophobic group but
comparable or increased levels of mitochondrial tRNA for
the polar group relative to those in brain. The two
reproductive tissues have decreased levels of mitochondrial
tRNA for the small group than those in brain. These
differences may reﬂect the amino acid availability in these
Table 1. Suggested Codon Usage Preferences in Each Tissue Relative to Brain According to tRNA Expression
tRNA Probe
a Preferred Codons Liver
b Vulva Testis Ovary Thymus Lymph Node Spleen HeLa/HEK293
Arg-ICG CGU/C þþ     
Arg-YCG CGG/A þþ    
Arg-CCT AGG þ þþ
Arg-TCT AGA þþþþ þ þ
Gly-SCC GGC/U/G þþ þ
Gly-TCC GGA þþ þ þ þ  
Ile-rAT AUU/C þ        þ þþ þ þ
Ile-TAT AUA        þ þ þ þ
Leu-wAG CUU/C/A þ  
Leu-CAG CUG þþ  þ
Leu-CAA UUG þ
Leu-TAA1 UUA  þ þ
Leu-TAA2
c UUA ? ? ? ? þþ þ   ?
Lys-CTT AAG þ 
Lys-TTT1 AAA       
Lys-TTT2 AAA           
Lys-TTT3 AAA           
Ser-CGA UCG      þ
Ser-wGA UCU/C/A       
Ser-GCT AGU/C þ   
Thr-mGT ACU/C/G       
Thr-TGT1 ACA    þ þ
Thr-TGT2 ACA þþþþ þ þ þ þ
Thr-CGT2
c ACG     
Val-mAC GUU/C/G þþ þ þ þ þ þ
Val-TAC GUA þþ  þ þ þ
mLeu-TAG CUU/C/A/G        
mLeu-TAA UUA/G þþ þ þ þ   þ
mSer-TGA UCU/C/A/G þþþ þ þ
mSer-GCT AGC/U     þ þ þ
aS, C,G; Y, C,T; r, I,G; h, I,C,T; w, I,T; m, I,C; I, inosine; mLeu and mSer, mitochondrial encoded tRNA probes.
bTissue/brain tRNA ratios: blank, 0.8 to 1.25; þ, 1.25 to 2; þþ , .2;  , 0.5 to 0.8;    , ,0.5.
cThr-CGT1 in all tissues and Leu-TAA2 in some tissues show signals below the detection limit.
doi:10.1371/journal.pgen.0020221.t001
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tRNA Expression in Human Tissuestissues, although how this affects RNA polymerase III tran-
scription is unclear.
Correlating Relative tRNA Abundance to Codon Usage of
Tissue-Specific Gene
The differential expression of tRNA isoacceptors can
potentially be used to control translation via the codon
usage of speciﬁc genes. However, it is unclear to which genes
and at which stages of cellular development and differ-
entiation this mechanism may be applied. Codon preferences
are clearly present in some tissue-speciﬁcally expressed genes
[14], although this bias has also been suggested to represent
regional variations rather than selection for translational
performance [33].
We attempted to ﬁnd potential correlations between the
codon usage of tissue-speciﬁcally expressed genes to the
relative tRNA abundance among these tissues (Figure 4). In
bacteria and yeast, correlations of the abundance of tRNA
isoacceptors to codon usage are derived primarily from genes
that are translated at high levels (e.g., ribosomal proteins).
Adapting this strategy, thresholds were algorithmically
established to determine the top 13 to 43 tissue-speciﬁc
transcripts according to the Human GeneAtlas GNF1H
gcRMA dataset at http://symatlas.gnf.org/SymAtlas [2]. Gene
sequences for the most highly expressed tissue-speciﬁc
transcripts were then compiled and analyzed for codon
content at http://bioinformatics.org/sms [34]. Some gene
information was not included due to ambiguity of data or
nomenclature. Table 2 lists the tissue-speciﬁc threshold
expression levels used for this analysis and the tabulated
gene and codon counts. The dataset contains 7,737 to 21,163
codons for six tissues: brain, liver, testis, ovary, thymus, and
lymph node (we were unable to carry out this analysis for
vulva and spleen). To mimic the relative tRNA abundance
measurements, the raw codon count is normalized to the total
number of codons in every tissue, and the sum of each
normalized codon count from nonbrain tissues is divided by
the sum of the same count from brain (Tables S5 and S6).
The correlation of codon usage versus relative tRNA
abundance (not divided by median values) was explored in
three ways. First, all data points from the same tissue are
plotted. For liver and brain, a linear ﬁt of this plot gives an r-
Figure 4. Linear Correlation of Relative tRNA Abundance to Codon Usage of Tissue-Specific Genes that Are Expressed at High Levels
The r- and p-values are indicated in each graph.
(A) Liver/brain, all data points. Excluding the two outlying data points (circled) gives a linear fit with r ¼ 0.78, p , 0.0001, and a slope of 1.0 6 0.2.
Inclusion of these two data points gives a linear fit with r ¼ 0.62, p ¼ 0.00098, and a slope of 0.8 6 0.2.
(B) Three individual isoacceptors across all five tissues show linear correlation with r ¼ 0.90 to 0.94 and p ¼ 0.016 to 0.039.
(C) Two sets of four tRNA
Arg isoacceptors in liver and thymus show linear correlation with r ¼ 0.93 and 0.97 and p ¼ 0.067 and 0.033, respectively.
doi:10.1371/journal.pgen.0020221.g004
Table 2. Expression Threshold Used in the Compilation of Codon













Brainstem 30 1.5 36 (36) 17,604
Liver 200 1.5 43 (43) 19,338
Lymph 25 3 22 (13) 7,737
Ovary 5 1.5 33 (27) 21,163
Testis 75 1.5 41 (39) 12,973
Thymus 20 1.5 27 (23) 9,703
aNumber of genes found according to the threshold (in parentheses), number of genes
whose codons are compiled to give the number of codons (far right column).
doi:10.1371/journal.pgen.0020221.t002
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tRNA Expression in Human Tissuesvalue of 0.78 and a p-value of ,0.0001, a statistically signiﬁcant
correlation (Figure 4A). Similar correlations for testis, ovary,
thymus, lymph node, and brain are much weaker and not
statistically relevant (unpublished data). The fold over median
expression threshold for liver is the highest among all tissues
examined (Table 2), suggesting that the liver-speciﬁc genes are
expressed at much higher levels than other tissue-speciﬁc
genes. The high expression levels of liver-speciﬁc genes may
explain why a signiﬁcant tRNA abundance–codon usage
correlation is only found in liver versus brain. Second, data
points for each tRNA isoacceptor are plotted across ﬁve





found with r-values from 0.90 to 0.94 and p-values from 0.016
to 0.039 (Figure 4B). Similar correlations for other isoaccep-
tors are not statistically signiﬁcant. Third, only two amino
acids (arginine and leucine) have more than three data points
and they are plotted for each tissue. Linear correlations
among the four tRNA
Arg for two tissues (liver and thymus) can
be found with r-values of 0.93 and 0.97 and p-values of 0.067
and 0.033, respectively (Figure 4C). Similar correlations for
other tissues are much weaker.
Conclusions
We have found that human tRNA expression varies by as
much as tenfold among human tissues. Given the central role
of tRNA in protein synthesis, this wide variation of tRNA
abundance may reﬂect translational control via the avail-
ability of certain tRNAs. Since tRNA is the dominant ligand
for the multitasking protein EF-1a, variations in tRNA levels
may provide a mechanism to link translation with the
dynamics of the cytoskeleton. Transcriptional control of
tRNA genes may therefore play a role in the function of
human tissues or possibly in cellular development and
differentiation. tRNA abundance may also play a role in
translational control of highly expressed, tissue-speciﬁc genes
via their codon usage. Determination of tRNA abundance
and charging levels [20] for differentiating cells or cells
undergoing adaptation may reveal previously unseen con-
nections between translation and other cellular processes.
Materials and Methods
Materials. Total RNA from eight human tissues was purchased
from Stratagene (http:/www.stratagene.com): brain (No. 540005, No.
735006), liver (No. 735017), vulva (No. 735067), testis (No. 735064),
ovary (No. 735260), thymus (No. 540141), lymph node (No. 540021),
and spleen (No. 540035). After the microarray measurements were
completed, it was found that the tissue RNA samples from Stratagene
underwent an LiCl precipitation step which is known to result in the
loss of small RNAs [35]. We subsequently found that the loss of tRNA
is quite minimal when the concentration of the total RNA was greater
than 1.5 lg/ll prior to the addition of LiCl and that the total amount
of tRNA in brain was similar to that in HeLa isolated using a different
protocol (Figure S2). The Stratagene RNAs we used are certiﬁed for
microRNA studies. It is clear that under certain conditions, LiCl can
precipitate microRNAs that are 3.5 times smaller than tRNAs. These
results lend conﬁdence that it is possible to perform LiCl
precipitation and not affect tRNA studies.
The total RNA from the HeLa and HEK293 cell lines were obtained
using RNAwiz (Ambion, http:/www.ambion.com) according to man-
ufacturer’s manuals. This procedure does not include LiCl precip-
itation or other known steps biasing against tRNAs.
The three tRNA standards, E. coli tRNA
Lys (No. R6018), E. coli
tRNA
Tyr (No. R0258), and yeast tRNA
Phe (No. R4018), were purchased
from Sigma-Aldrich (http:/www.sigmaaldrich.com) and used without
further puriﬁcations.
tRNA microarrays. Themicroarrayexperimentconsistsoffoursteps
starting from total RNA: (i) deacylation to remove remaining amino
acids attached to the tRNA, (ii) selective Cy3/Cy5 labeling of tRNA, (iii)
hybridization with prefabricated arrays, and (iv) data analysis.
For deacylation, 0.25 lg/ll total RNA premixed with the three
tRNA standards at 0.17 lM each was incubated in 100 mM Tris-HCl
(pH 9.0) at 37 8C for 30 min. The solution was neutralized by the
addition of an equal volume of 100 mM Na-acetate/acetic acid (pH
4.8) plus 100 mM NaCl, followed by ethanol precipitation. Deacylated
total RNA was dissolved in water, and its integrity was examined using
agarose gel electrophoresis.
For Cy3/Cy5labeling, tRNA in thetotal RNAmixture wasselectively
labeled with either Cy3 or Cy5 ﬂuorophore using an enzymatic
ligation method described previously [19,20]. The ligation reaction
depends on the presence of the universally conserved 39CCA
nucleotides in every tRNA. Two different labeling oligonucleotides
for the T4 DNA ligase were used in this work (Figure 1A). Both
oligonucleotides are designed and shown to have insigniﬁcant bias for
Cy3 and Cy5 dyes (Figure 1B and unpublished data). Oligo-1 contains
5-aminoallyl-U, and the Cy3 and Cy5 ﬂuorophores were attached after
the ligation step upon reactions with succimidyl esters of Cy3 or Cy5
(Amersham Biosciences, http://www.amersham.com, described in [20]).
Oligo-2 contains an 8–base pair hybrid helix and either a Cy3 or Cy5
ﬂuorophore preattached in the loop. The ligation reaction used an
approximately 1 lM concentration of puriﬁed T4 DNA ligase for
Oligo-1 but only 0.5 U/ll T4 DNA ligase (US Biochemicals, http://www.
usbweb.com) for Oligo-2. Hence, the ligation of Oligo-2 required
substantially less T4 DNA ligase compared to Oligo-1.
Hybridization was performed at 60 8C overnight with 1 lg each of
Cy3- or Cy5-labeled total RNA mixture using Oligo-1 and 1 lg of Cy3-
labeled total RNA and 2.5 lg of Cy5-labeled total RNA using Oligo-2
(because only 40% of Oligo-2 used in this work contained the Cy5
ﬂuorophore). Multiple arrays were run using the brain reference
sample labeled with either Cy3 or Cy5.
The microarray printing and hybridization conditions were the
same as those in bacterial tRNA studies [19,20]. DNA oligonucleotide
probes were designed on the basis of the 2001 version of the human
genome [36]. Subsequent revision of the human genome sequences
and tRNA annotations showed that 136 probes are useful for our
study. They included 42 probes for human nuclear encoded tRNA
genes, 21 probes for human mitochondrial encoded tRNA genes, 18
probes for mouse mitochondrial encoded tRNA genes, ten probes for
Drosophila nuclear tRNA genes, 34 probes for C. elegans nuclear tRNA
genes, three probes for bacterial and yeast tRNA standards, and eight
probes for human tRNA hybridization controls. Nonhuman probes
were used as speciﬁcity controls for hybridization of human samples.
Eighteen replicates of each probe were printed on each array. The
descriptions and sequences of the DNA oligonucleotide probes used
for human nuclear and mitochondrial tRNA genes are provided in
Tables S1 through S4.
For data analysis, arrayswere scannedusing GenePix 4000b scanner
(Axon Instruments, http://www.axon.com) to obtain ﬂuorescence
intensities and the Cy5/Cy3 ratio per pixel at each probe spot. The
averaged Cy5/Cy3 ratio per pixel at each probe spot was ﬁrst
normalized to an averaged value of the three tRNA standards prior to
subsequentanalysis.Foralltissuesamples,thebraintotalRNAwasused
asthereferencesampleatequalamountsoftotalRNAasdeterminedby
the UV absorbance. tRNA constitutes up to 15% of total RNA.
Supporting Information
Figure S1. Relative Ratios of Each Human tRNA Probe for Liver,
Vulva, Testis, Thymus, and Lymph Node versus Brain
Found at doi:10.1371/journal.pgen.0020221.sg001 (55 KB PDF).
Figure S2. Recovery of tRNA Following LiCl Precipitation
Found at doi:10.1371/journal.pgen.0020221.sg002 (36 KB PDF).
Table S1. Human Probes for Chromosomal Encoded tRNA Genes
Found at doi:10.1371/journal.pgen.0020221.st001 (10 KB PDF).
Table S2. Sequences of Human Probes for Chromosomal Encoded
tRNA Genes
Found at doi:10.1371/journal.pgen.0020221.st002 (17 KB PDF).
Table S3. Human Probes for Mitochondrial Encoded tRNA Genes
Found at doi:10.1371/journal.pgen.0020221.st003 (8 KB PDF).
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tRNA Genes
Found at doi:10.1371/journal.pgen.0020221.st004 (12 KB PDF).
Table S5. Gene Sequences for Tissue-Speciﬁcally Expressed Gene
According to mRNA Expression Data
Found at doi:10.1371/journal.pgen.0020221.st005 (429 KB XLS).
Table S6. Averaged Ratios of tRNA Abundance for Seven Tissues
Relative to Brain
Found at doi:10.1371/journal.pgen.0020221.st006 (34 KB XLS).
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